Influenza, COVID-19 Flashcards

1
Q

What is influenza?

A

Viral respiratory tract infection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the clinical presentation for influenza that is different from common cold?

A

Influenza: onset is abrupt; fever, body aches, chills, fatigue, body weakness, Chest discomfort, Cough, HA are usual. Sneezing, stuffy nose, sore throat are sometimes.

Common cold: Onset is gradual. Sneezing, stuffy nose, sore throat usual.
The other S&S are slight/rare

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

How is influenza tracked in SG?

A

Bimodal distribution
Dec-Feb
May-July

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Which influenza types are clinically significant?

A

Influenza A - humans, swine, equine, avian, multiple other species
Clinical presentation: most severe illness, sig mortality in young persons; Epidemics and pandemics

Influenza B: Humans only
Clinical Presentation: Severe illness in older adults or high risk persons; Less severe epidemics

Influenza C (not clinically sig but exists): human, swine
Clinical presentation: mild respiratory illness wo seasonality; No epidemics
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are the complications of influenza?

A
  • Viral pneumonia (normally URTI first, but then go to LRTI –> becomes viral)
  • Post-influenza bacterial pneumonia (particularly those caused by S. aureus) - mortality >30%
  • respiratory failure
  • exacerbate underlying pulmonary or cardiac comorbidities
  • febrile seizures
  • myocarditis or pericarditis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Who are at high-risk for influenza-related complications?

A
  • children <5yo
  • elderly >= 65yo
  • preg women or within 2 wks post-partum
  • residents of nursing homes or long-term care facilities
  • obese ind with BMI >= 40kg/m2
  • ind w chronic medical conditions (e.g. asthma, COPD, HF, DM, CKD, immunocompromised, etc.) - very specific conditions only, does not include HTN, HLD
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

How to prevent influenza? (3 prevention strategies)

A

1) Good personal hygiene
- wash your hands
- minimise touching of eyes, nose or mouth
- cover nose and mouth when coughing/ sneezing
- use a serving spoon when sharing food

2) Healthy lifestyle
- balanced diet
- exercise regularly
- adequate sleep
- dont smoke

3) Vaccination
- best prevention
- inactivated trivalent or quadrivalent vaccine
- adm IM once per yr
- indicated for all ind >= 6mths of age and above

~ Chemoprophylaxis (use drug to prevent influenza): not routinely recommended; to avoid sub-therapeutic dosing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

How to diagnose influenza?

A
  • Viral cultures not recommended
  • Molecular tests available for use of practice
    ~ limited use in outpatient: mostly treated empirically
    ~ used inpatient: RT-PCR
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

When to treat influenza?

A
  • for documented/ suspected influenza:
    ~ initiate asap within 48h of smx onset for ind who fulfill any ONE of the following:
    – hospitalised
    – high-risk for complications
    – severe, complicated, or progressive illness

~ May be considered for others (outpatients) presenting within 48h of smx onset

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

When is antiviral given?

A

When antiviral med is started within this time window - greatest benefit in preventing influenza related complications

Short time interval - acceptable for med to be started empirically

Upon -ve PCR to conclude no influenza / alternative diagnosis hat explain pts smx, antiviral can be stopped

Still doubtful conflicting - whether benefit to start antiviral when pt present smx beyond 48hours

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are the treatment options for influenza?

A

Antiviral - Oseltamivir
1ST LINE: active against Influenza type A and B

  • 75mg PO BD for 5d
  • Renally dose adjusted

Duration may be prolonged in pts who are immunocompromised/ critically ill - up to total of 10d
MOA: neuraminidase inhibitor
- interferes w protein cleavage
- inhibits release of new virus

Well-tolerated: HA; Mild GI effects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are the common S&S for both influenza and COVID-19?

A

Both COVID-19 and flu have varying degrees of S&S, from asymptomatic to severe smx. Common smx:

  • Fever or feeling feverish/having chills
  • Cough
  • Shortness of breath or difficulty breathing
  • Fatigue (tiredness)
  • Sore throat
  • Runny or stuffy nose
  • Muscle pain or body aches
  • Headache
  • Vomiting and diarrhea
  • Change in or loss of taste or smell, although this is more frequent with COVID-19.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

How Long Symptoms Appear After Exposure and Infection for influenza and COVID?

A

Similarities: 1 or more days can pass between when a person becomes infected and when he or she starts to experience illness smx.

Differences:
COVID-19 take longer to experience symptoms than if they had flu.

Flu: experiences smx anywhere from 1 - 4d after infection.

COVID-19: experiences smx about 5d after being infected, but smx can appear 2 - 14d after infection.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

How Long Someone Can Spread the Virus for Influenza VS COVID?

A

Similarities: possible to spread the virus for at least 1 day before experiencing any smx.

Differences:
COVID-19 could be contagious for a longer time than if they had flu.

Flu: contagious for about 1 day before they show symptoms.

Older children and adults with flu appear to be most contagious during the initial 3-4 days of their illness but many people remain contagious for about 7 days.

Infants and people with weakened immune systems can be contagious for even longer.

COVID-19: still under investigation.
possible for people to spread the virus for about 2 days before experiencing signs or symptoms (or possibly earlier) and remain contagious for at least 10 days after signs or symptoms first appeared. If someone is asymptomatic or their symptoms go away, it’s possible to remain contagious for at least 10 days after testing positive for COVID-19. People who are hospitalized with severe disease and people with weakened immune systems can be contagious for 20 days or longer.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

How does influenza and COVID spreads?

A

spread from person-to-person between people who are in close contact with one another –> cough/ sneeze –> inhaled into lungs
spread by inhalation or even touching

Differences:
COVID-19 is generally more contagious than flu viruses. Also, COVID-19 has been observed to have more superspreading events than flu. This means the virus that causes COVID-19 can quickly and easily spread to a lot of people and result in continual spreading among people as time progresses.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

People at Higher-Risk for Severe Illness for Influenza and COVID?

A

Similarities: severe illness and complications. Those at highest risk include:

  • Older adults
  • People with certain underlying medical conditions (including infants and children)
  • Pregnant people

Differences:
COVID-19 seems to cause more serious illnesses in some people. Serious COVID-19 illness resulting in hospitalization and death can occur even in healthy people.

Some people that had COVID-19 can go on to develop post-COVD conditions or multisystem inflammatory syndrome (MIS)

17
Q

Complications of influenza and COVID?

A

Similarities:

  • Pneumonia
  • Respiratory failure
  • Acute respiratory distress syndrome
  • Sepsis
  • Cardiac injury (e.g., heart attacks and stroke)
  • Multiple-organ failure (resp failure, kidney failure, shock)
  • Worsening of chronic medical conditions (involving lungs, heart, or nervous system or DM)
  • Inflammation of heart, brain, or muscle tissues
  • Secondary infections (bacterial/ fungal infections that can occur in people who have already been infected with flu/ COVID-19)

Differences:
Flu: Most recover on their own in a few days to two weeks, but some will experience severe complications, requiring hospitalization (listed above). Secondary bac infections are more common with influenza than with COVID-19.

Diarrhoea is more common in young children with flu than in adults with flu.

COVID: Additional complications:

  • Blood clots in the veins and arteries of the lungs, heart, legs or brain
  • Multisystem Inflammatory Syndrome in Children (MIS-C) and in Adults (MIS-A)
  • Long COVID is a range of symptoms that can last weeks or months after first being infected with the virus that causes COVID-19 or can appear weeks after infection. Long COVID can happen to anyone who has had COVID-19, even if their illness was mild, or if they had no symptoms.
18
Q

What are the approved drugs/ treatments for Influenza and COVID?

A

Similarities:
People at higher risk of complications or who have been hospitalized for COVID-19 or flu should receive supportive medical care to help relieve symptoms and complications.

Differences:
Flu: Prescription influenza antiviral drugs are FDA-approved to treat flu.

People who are hospitalized with flu or who are at increased risk of complications and have flu symptoms are recommended to be treated with antiviral drugs as soon as possible after illness onset.

COVID-19: NIH has developed guidance on treatment of COVID-19, which is regularly updated as new evidence on treatment options emerges.

FDA has approved one drug, remdesivir (Veklury®), to treat COVID-19.

FDA has issued emergency use authorizations (EUAs) to allow healthcare providers to use investigational products that are not yet approved, or that are approved for other uses, to treat patients with COVID-19 if certain legal requirements are met.

19
Q

What are the vaccines available for influenza and COVID?

A

Similarities:
Vaccines for COVID-19 and flu are approved and/or authorized for emergency use (EUA) by FDA.

Differences:
Flu: There are multiple FDA-licensed influenza vaccines produced annually to protect against the 4 flu viruses that scientists expect will circulate each year.

COVID-19: Three COVID-19 vaccines have been authorized for use by FDA under an EUA. Other vaccines to prevent COVID-19 are under development.